2017 American Transplant Congress
Avascular Necrosis in Kidney Transplant Recipients: Recent Data from a Cohort Study.
Avascular osteonecrosis (AVN) is the most disabling bone complication after kidney transplantation (KT). Its incidence decreased from 15% to 4% after the introduction of cyclosporine…2017 American Transplant Congress
Outcomes After Hysterectomy in Patients with End Stage Renal Disease.
INTRODUCTION:Hysterectomy is one of the most common gynecologic surgeries performed on women, including women with ESRD awaiting kidney transplantation. Despite this, studies of hysterectomy among…2017 American Transplant Congress
Death After Kidney Transplantation: Assessment of Pre- and Peri-Transplant Risk Factors and of Time-Varying Risk Factors from the Post-Transplant Course.
Deaths over a period of up to 10 years post-transplantation (Tx) and the associated risk factors were examined in patients (pts) with protocol biopsies (total…2017 American Transplant Congress
Early Outcomes of Kidney Transplantation When Comparing Waist-to-Hip Ratio vs. Body Mass Index.
Introduction - High body mass index (BMI) is a concern for kidney transplantation due to wound infections and other surgical complications. BMI has been used…2017 American Transplant Congress
Utility of Electron Microscopy in Kidney Transplant Biopsies.
1LSUHSC, New Orleans, LA; 2Children's Hospital, New Orleans, LA
Background: Banff 2013 criteria recommends performing ultra-structural studies with electron microscopy (EM) in most kidney transplant (KT) biopsies if the technology is available. We aimed…2017 American Transplant Congress
Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race.
Transplant, MUSC, Charleston, SC
There is strong evidence that both tacrolimus (FK) and mycophenolate (MMF) have improved outcomes in kidney transplantation; yet, the impact of exposure of these immunosuppressants…2017 American Transplant Congress
TNF[part]-I After Kidney Transplantation.
Department of Medicine, Division of Nephrology, University of Wisconsin, Madison, WI
Infliximab, adalimumab and etanercept are monoclonal antibodies which inhibit tumor necrosis factor alpha (TNF[part]-I) and are used in the treatment of inflammatory diseases such as…2017 American Transplant Congress
The Treatment of the Graft and the Recipient with α-Lipoic Acid Improves the Delay Graft Function Severity in the Human Kidney Transplant.
A previous pilot clinic trial had showed that treatment of the donor and recipient with a potent anti-oxidant such as α-lipoc acid (ALA) reduces the…2017 American Transplant Congress
Early and Late High Intrapatient Variability of Tacrolimus Levels Can Predict Late Renal Allograft Rejection.
Introduction Nonadherence to immunosuppressive medication can start any time after transplantation and is associated with rejection and graft loss. We have previously shown that high…2017 American Transplant Congress
Benefits of Multimodal Enhanced Recovery Pathway in Patients Undergoing Kidney Transplantation.
Background: Use of Enhanced Recovery After Surgery (ERAS) pathways have been shown to improve patient recovery in several surgical specialties; however, its' effectiveness in kidney…